
Hsa Pharma Private Limited
About Hsa Pharma Private Limited
Data last updated:
Hsa Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 June 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24232TN2012PTC086279. Its GSTIN is 33AACCH9376H1ZD (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Dinesh Kumar Kothari and Roopa Kothari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Old No.16 New No.17 1st Floor Samanthi Street Brindavan Nagar Koyembedu, Chennai, Tamil Nadu, India – 600092.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.52 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹3.35 Lakh (net margin 0.4%) and EBITDA of ₹4.93 Lakh (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 5% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Hsa Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressOld No.16 New No.17 1st Floor Samanthi Street Brindavan Nagar Koyembedu, Chennai, Tamil Nadu, India – 600092
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Hsa Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hsa Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Hsa Pharma Private Limited, buy the company report.
Financials of Hsa Pharma Private Limited
FY 2025 filings availableHsa Pharma Private Limited reported revenue of ₹7.52 Cr (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.93 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hsa Pharma Private Limited, buy the company report.
Board of directors of Hsa Pharma Private Limited
Hsa Pharma has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dinesh Kumar Kothari | Director | 26 Sep 2014 | 12 Years 1 Months | Current |
| Roopa Kothari | Director | 26 Sep 2014 | 12 Years 1 Months | Current |
Peer comparison
Hsa Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Excel Lifecare Private Limited | ₹7.54 Cr (FY 2024) | 8.0% | Bilaspur, Chhattisgarh, India | |||
| Trio Biotech Private Limited | ₹7.52 Cr (FY 2025) | 37.0% | Bokaro, Jharkhand, India | |||
| Shakambhari Medical Private Limited | ₹7.52 Cr (FY 2025) | 87.0% | Lucknow, Uttar Pradesh, India | |||
| Hsa Pharma Private Limitedthis company | ₹7.52 Cr (FY 2025) | ₹3.35 Lakh | 0.4% | -12.0% | Chennai, Tamil Nadu, India | |
| Medicross Pharma-Chem Limited | ₹7.48 Cr (FY 2025) | 6.0% | Delhi, India | |||
| Ishjas Pharma Private Limited | ₹7.47 Cr (FY 2024) | -36.0% | Delhi, India | |||
| Dr.Goyal Medical Private Limited | ₹7.46 Cr (FY 2024) | 6.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Hsa Pharma Private Limited, buy the company report.
Auditor
Hsa Pharma Private Limited is audited by S S P JAIN AND ASSOCIATES LLP for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S S P JAIN AND ASSOCIATES LLP | FY 2020 | S200062 |
Shareholding
The shareholding of Hsa Pharma Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Hsa Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hsa Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hsa Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hsa Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AACCH9376H1ZD | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Hsa Pharma Private Limited, buy the company report.
Recent activity
Hsa Pharma Private Limited has 8 board changes on record since 2013: 2 appointments and 6 cessations. The latest: Rasheed Syed Rafeek ceased to be Director on 01 Feb 2016.
Frequently asked questions
Hsa Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 June 2012 (14+ years old) and is registered under CIN U24232TN2012PTC086279.
Hsa Pharma has 2 current directors:
- Dinesh Kumar Kothari - Director
- Roopa Kothari - Director
The latest financial statements of Hsa Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Hsa Pharma is 33AACCH9376H1ZD, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Hsa Pharma is U24232TN2012PTC086279. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hsa Pharma was incorporated on 13 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Hsa Pharma by revenue are Excel Lifecare Private Limited, Trio Biotech Private Limited, Shakambhari Medical Private Limited, Medicross Pharma-Chem Limited, Ishjas Pharma Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Rasheed Syed Rafeek ceased to be Director on 01 Feb 2016. Rasheed Syed Siddiqe ceased to be Managing Director on 01 Feb 2016. Dinesh Kumar Kothari ceased to be Director on 29 Sep 2015. Hsa Pharma has 8 board changes on record in total.
The registered office of Hsa Pharma is at Old No.16 New No.17 1st Floor Samanthi Street Brindavan Nagar Koyembedu, Chennai, Tamil Nadu, India – 600092.
Hsa Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Hsa Pharma is compliant as of 13 August 2026. The company is actively filing with the Registrar of Companies.

